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A B S T R A C T
Background
Worldwide at least 100 million people are thought to have prevalent cardiovascular disease (CVD). This population has a five times
greater chance of suffering a recurrent cardiovascular event than people without known CVD. Secondary CVD prevention is defined
as action aimed to reduce the probability of recurrence of such events. Drug interventions have been shown to be cost-effective in
reducing this risk and are recommended in international guidelines. However, adherence to recommended treatments remains sub-
optimal. In order to influence non-adherence, there is a need to develop scalable and cost-effective behaviour-change interventions.
Objectives
To assess the effects of mobile phone text messaging in patients with established arterial occlusive events on adherence to treatment,
fatal and non-fatal cardiovascular events, and adverse effects.
Search methods
We searchedCENTRAL,MEDLINE, Embase, the Conference Proceedings Citation Index - Science onWeb of Science on 7November
2016, and two clinical trial registers on 12 November 2016. We contacted authors of included studies for missing information and
searched reference lists of relevant papers. We applied no language or date restrictions.
Selection criteria
We included randomised trials with at least 50% of the participants with established arterial occlusive events. We included trials
investigating interventions using short message service (SMS) or multimedia messaging service (MMS) with the aim to improve
adherence to medication for the secondary prevention of cardiovascular events. Eligible comparators were no intervention or other
modes of communication.
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Data collection and analysis
We used standard methodological procedures expected by Cochrane. In addition, we attempted to contact all authors on how the SMS
were developed.
Main results
We included seven trials (reported in 13 reports) with 1310 participants randomised. Follow-up ranged from one month to 12 months.
Due to heterogeneity in the methods, population and outcome measures, we were unable to conduct meta-analysis on these studies.
All seven studies reported on adherence, but using different methods and scales. Six out of seven trials showed a beneficial effect of
mobile phone text messaging for medication adherence. Dale 2015a, reported significantly greater medication adherence score in the
intervention group (Mean Difference (MD) 0.58, 95% confidence interval (CI) 0.19 to 0.97; 123 participants randomised) at six
months. Khonsari 2015 reported less adherence in the control group (Relative Risk (RR) 4.09, 95% CI 1.82 to 9.18; 62 participants
randomised) at eight weeks. Pandey 2014 (34 participants randomised) assessed medication adherence through self-reported logs
with 90% adherence in the intervention group compared to 70% in the control group at 12 months. Park 2014a (90 participants
randomised) reported a greater increase of the medication adherence score in the control group, but also measured adherence with an
eventmonitoring system for a number of medications with adherence levels ranging from 84.1% adherence to 86.2% in the intervention
group and 79.7% to 85.7% in the control group at 30 days. Quilici 2013, reported reduced odds of non-adherence in the intervention
group (Odds Ratio (OR) 0.43, 95% CI 0.22 to 0.86, 521 participants randomised) at 30 days. Fang 2016, reported that participants
given SMS alone had reduced odds of being non-adherent compared to telephone reminders (OR 0.40 95% CI 0.18 to 0.63; 280
patients randomised). Kamal 2015 reported higher levels of adherence in the intervention arm (adjusted MD 0.54, 95% CI 0.22 to
0.85; 200 participants randomised).
Khonsari 2015 was the only study to report fatal cardiovascular events and only reported two events, both in the control arm. No study
reported on the other primary outcomes. No study reported repetitive thumb injury or road traffic crashes or other adverse events that
were related to the intervention.
Four authors replied to our questionnaire on SMS development. No study reported examining causes of non-adherence or provided
SMS tailored to individual patient characteristics.
The included studies were small, heterogeneous and included participants recruited directly after acute events. All studies were assessed
as having high risk of bias across at least one domain. Most of the studies came from high-income countries, with two studies conducted
in an upper middle-income country (China, Malaysia), and one study from a lower middle-income country (Pakistan). The quality
of the evidence was found to be very low. There was no obvious conflicts of interest from authors, although only two declared their
funding.
Authors’ conclusions
While the results of this systematic review are promising, there is insufficient evidence to draw conclusions on the effectiveness of
text message-based interventions for adherence to medications for secondary prevention of CVD. Sufficiently powered, high-quality
randomised trials are needed, particularly in low- and middle-income countries.
P L A I N L A N G U A G E S U M M A R Y
Text messaging to help people suffering from heart disease adhere to medications
Review question
We reviewed the evidence about the effect of text messaging on medication adherence in people with heart disease. We found seven
studies including 1310 participants.
Background
Worldwide, at least 100 million people suffer from heart disease. While there are numerous cost-effective treatments, the majority of
these individuals are not taking the medications that they need to keep themselves from suffering more heart problems. One possible
method of helping people with heart disease to take their medications is through the use of text message-based reminders.
Study characteristics
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The evidence is current to November 2016. We found seven studies that compared using text messages to not using text messages, with
follow-up ranging from one month to 12 months.
Key results
While the results of these studies appear promising that text messages can help people take their medicines, the studies were small and
utilised very different methods and definitions. For that reason, we were not able to compile the findings of the studies. Most of the
studies came from high-income countries, and were primarily conducted on men. No studies reported any bad side effects from using
text messages. There was no obvious conflicts of interest from authors, although only two declared their funding.
Quality of the evidence
The quality of evidence from these studies was very low. Additional high-quality studies on the use of text messages for encouraging
people suffering from heart disease to take their medication regularly are needed, particularly in low- and middle-income countries.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Mobile phone text messaging to improve medicat ion adherence in secondary prevent ion of cardiovascular disease
Patient or population: pat ients with established arterial occlusive events
Setting: hospital/ cardiac rehabilitat ion facility
Intervention: mobile phone text messaging
Comparison: no intervent ion or other modes of communicat ion
Outcomes Impact of participants
(studies)
Quality of the evidence
(GRADE)
Adherence to treatment Six out of seven trials showed
a benef icial ef fect of mo-
bile phone text messaging for
medicat ion adherence. One
trial showed an improved ad-
herence score for the control
group compared to the inter-
vent ion group (smallest and
shortest trial)
1310
(7 RCTs)
⊕©©©
VERY LOW 123
GRADE Working Group grades of evidence
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
Moderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of
the ef fect, but there is a possibility that it is substant ially dif f erent
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate
of the ef fect
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent
f rom the est imate of ef fect
1 Downgraded one level of evidence due to unclear or high risk of bias for all studies in at least one domain.
2 Downgraded one level of evidence due to inconsistent report ing of outcome.
3 Downgraded one level of evidence due to imprecision of the results in one study and dif ferent direct ion of ef fect in another
study.
B A C K G R O U N D
Description of the condition
Worldwide, there are an estimated 13 million deaths due to coro-
nary heart disease or stroke each year, and 80% of these deaths
occur in low- and middle-income countries (Lozano 2012). It is
estimated that approximately three times as many people will suf-
fer non-fatal cardiovascular events and that each year 35 million
people have an acute coronary or cerebrovascular event. World-
wide, at least 100 million people are thought to have prevalent car-
diovascular disease (CVD) (Chambless 1997; WHO 2002; Yusuf
2011). This population has a five times greater chance of suffer-
ing a new cardiovascular event than people without known CVD
(Kerr 2009).
Secondary CVD prevention is defined as action aimed to re-
duce the probability of recurrence of a cardiovascular event in pa-
tients with known atherosclerotic CVD. There are two main as-
pects to secondary CVD prevention: risk factor management and
medications. Drug interventions (such as antiplatelet therapy, an-
giotensin-converting enzyme (ACE) inhibitors/ angiotensin recep-
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tor blockers (ARBs), beta-blockers and statins) have been shown to
be cost-effective in reducing the risk of subsequent fatal and non-
fatal cardiovascular events in patients with established atheroscle-
rotic cardiovascular diseases and are recommended in international
guidelines (ESC 2012; Smith 2011; WHO 2003a).
Unfortunately there is a well-documented knowledge-practice gap
in the implementation of these proven cost-effective interventions.
For example, the Prospective Urban Rural Epidemiology (PURE)
study reported that in low- and middle-income countries up to
75% of patients with known CVD are not using even one recom-
mendedmedication (Yusuf 2011). Even in high-income countries,
adherence to recommended treatments remains sub-optimal. A
cross-sectional survey of 12 European countries showed only 26%
of patients on antihypertensives achieving control of hyperten-
sion and less than 31% of patients on lipid-lowering medication
achieving cholesterol control (Kotseva 2010). It has been shown
that a considerable proportion of cardiovascular events could be
attributed to poor adherence, with 9% of cardiovascular events
in Europe attributed to poor adherence(Chowdhury 2013). It is
estimated that good adherence may be associated with a 20%
lower risk of CVD and a 35% reduction in all-cause mortality
(Chowdhury 2013). This evidence-practice gap might be influ-
enced by different factors, including health system issues such as
lack of accessibility and affordability; treatment complexity; or pa-
tients’ non-compliance with recommendations (Nieuwlaat 2013).
In order to influence non-compliance there is a need to develop
scalable and cost-effective behaviour-change interventions.
Description of the intervention
The global number of mobile phone subscribers is estimated at
nearly seven billion (ICT 2014). Even in low- and middle-in-
come countries the penetration rate of mobile phones is estimated
to be 90% (ICT 2014). The widespread ownership of mobile
phones and the possibility of automation leads to a potential to
deliver behaviour-change interventions to large numbers of people
at low cost. Mobile phone interventions are a potentially promis-
ing means to deliver messages to increase medication adherence.
The use of mobile devices such as phones to support the delivery
of medical care is commonly referred to as mHealth.
How the intervention might work
Mobile phone text messages have been shown to improve medica-
tion adherence for a variety of conditions including HIV (Sharma
2012). The development of messages should follow some theoret-
ical framework, and text messages should be developed specifically
for the target population and intervention (Abroms 2015). Text
messages as an intervention are relatively cost-effective and quick,
and do not require that the intended audience need to search for
information as it is delivered to them (Douglas 2013). Two recent
systematic reviews addressed the question of using mobile phones
for all types of medication adherence (Anglada-Martinez 2015;
Park 2014b). The majority of studies found significant improve-
ment in medication adherence through the use of text messages.
Overall, few adverse events have been reported with mobile phone
text messaging; however, potential rare adverse effects such as road
traffic crashes may occur.
Why it is important to do this review
While there is a great deal of enthusiasm for mHealth interven-
tions among researchers and policymakers, there is still limited ev-
idence for its effectiveness (Free 2013). Systematic reviews have re-
cently been conducted on adherence to medications and reported
promising results (Anglada-Martinez 2015; Park 2014b; Thakkar
2016); however, to date no systematic review has been conducted
evaluating specifically the effect of mobile phone text messaging
on secondary CVD prevention. Furthermore, no review has ex-
amined how text messages are created, and if short message ser-
vice (SMS) are tailored based on individual patient characteristics,
and if some patients benefit more than others from interventions.
Mobile phone text messaging is of particular interest in low- and
middle-income countries because of wider accessibility of mobile
phones with text-messaging capabilities than smart phones.
O B J E C T I V E S
To determine whether mobile phone text messaging is effective
in enhancing adherence to recommended medication in patients
with established arterial occlusive events.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We only included randomised controlled trials (RCTs). We in-
cluded studies reported as full text, those published as abstract
only, and unpublished data.
Types of participants
We included participants with established arterial occlusive events,
including coronary artery disease, cerebrovascular artery disease,
peripheral artery disease, and atherosclerotic aortic disease, for
whom antiplatelet, blood pressure loweringmedications and lipid-
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lowering medications are recommended. We included all stud-
ies regardless of where the patients were enrolled (community or
clinic). We only included studies where at least 50% of partici-
pants had established cardiovascular disease (CVD).
Types of interventions
We included trials comparing interventions using short message
service (SMS) ormultimediamessaging service (MMS) to improve
adherence to secondary cardiovascular prevention interventions.
We compared mobile phone messaging with no intervention, and
also with other modes of communication (for example, face-to-
face, postal letters, or phone calls). We did not exclude studies
based on how the text messages were developed, or if they were
one way versus two ways. We only included trials that included
adherence, butwe also included trials that includedboth adherence
and lifestyle modifications.
Types of outcome measures
Primary outcomes
1. Adherence to treatment (any definition used in trials)
2. Fatal cardiovascular events
3. Non-fatal cardiovascular events (coronary heart disease
(CHD), revascularisation, stroke)
4. Combined CVD event (fatal or non-fatal events)
Secondary outcomes
1. Surrogate outcomes according to the different interventions
recommended for secondary prevention including low-density
lipoprotein (LDL)-cholesterol for the effect of statins, blood
pressure for antihypertensive drugs, heart rate for the effect of
beta blockers, urinary 11-dehydrothromboxane B2 for the
antiplatelet effects of aspirin.
2. Adverse effects including self-reported road traffic crashes
and repetitive thumb strain
Search methods for identification of studies
Electronic searches
We identified relevant studies through systematic searches of the
following bibliographic databases on 7 November 2016.
1. Cochrane Central Register of Controlled Trials
(CENTRAL, Issue 10 of 12, 2016) in the Cochrane Library
2. MEDLINE in-Process & Other Non-Indexed Citations
and MEDLINE (OVID, 1946 to 7 November 2016)
3. EmbaseE Classic and Embase (OVID, 1947 to 4 November
2016)
4. Conference Proceedings Citation Index - Science (CPCI-S)
(1990 to 4 November 2016) on Web of Science (Thomson
Reuters)
The Cochrane sensitivity-maximising RCT filter was applied to
MEDLINE (Ovid) and adaptations of it to the other databases, ex-
cept CENTRAL (Lefebvre 2011). The search strategies are shown
in Appendix 1. We searched all databases from their inception to
the present, and imposed no restriction on language of publica-
tion.
We also
conducted a search of ClinicalTrials.gov (www.ClinicalTrials.gov)
and the World Health Organization’s International Clinical Trials
Registry Platform (ICTRP) (http://apps.who.int/trialsearch/) on
12November 2016. The search terms used are shown in Appendix
1.
We additionally searched for the clinical trial registry numbers of
identified ongoing studies on 14 January 2017 to see if their status
had changed and results had been published.
Searching other resources
We checked reference lists of all included primary studies and re-
viewed relevant systematic reviews and meta-analyses (Anglada-
Martinez 2015; Chow 2016; de Jongh 2012; Ershad Sarabi
2016; Hamine 2015; Misono 2010; Sahu 2014b; Thakkar 2016;
Vodopivec-Jamsek 2012) for additional references.
Data collection and analysis
Selection of studies
Two of four review authors (AJA, LF, NM, NS) independently
screened titles and abstracts for inclusion of all identified poten-
tial studies and decided to retrieve the full-text copies or to dis-
card them. If there were any disagreements, a third author arbi-
trated (PP or JPC). We retrieved full-text study reports/publica-
tions and two of three review authors (AJA, NM, NS) indepen-
dently screened the full text and identified studies for inclusion.
We resolved any disagreement through discussion. If necessary, a
third person (PP or JPC) arbitrated. We identified and excluded
duplicates and collated multiple reports of the same study so that
each study, instead of the report, is the unit of interest in the re-
view. We completed a PRISMA flow diagram and ’Characteristics
of excluded studies’ table.
Data extraction and management
We used a data collection form to extract study characteristics and
outcome data previously piloted on at least one study in the review.
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Two of three review authors (NM, OO, AJA) extracted study
characteristics from included studies. We extracted the following
study characteristics.
1. Methods: study design, total duration of study, study
setting, withdrawals, and date of study.
2. Participants: number, mean age, age range, gender,
condition, diagnostic criteria, smoking history, inclusion criteria,
and exclusion criteria.
3. Interventions: intervention, comparison, concomitant
medications, excluded medications, how text messages were
developed, behaviour-change technique, time from arterial
occlusive event, if SMS was personalised.
4. Outcomes: primary and secondary outcomes specified and
collected, and time points reported.
5. Notes: funding for trial, and notable conflicts of interest of
trial authors.
We resolved disagreements by consensus or by involving a third
person (PP or JPC). One review author (AJA) transferred data into
the Review Manager 5 (RevMan 2014) file. We double-checked
that data were entered correctly by comparing the data presented
in the systematic review with the study reports.
Assessment of risk of bias in included studies
Two of four review authors (CT, JM, AJA, NM) independently
assessed risk of bias for each study using the criteria outlined in the
CochraneHandbook for Systematic Reviews of Interventions (Higgins
2011). We resolved any disagreements by discussion. We assessed
the risk of bias according to the following domains.
1. Random sequence generation.
2. Allocation concealment.
3. Blinding of participants and personnel.
4. Blinding of outcome assessment.
5. Incomplete outcome data.
6. Selective outcome reporting.
7. Other biases including industry funding.
We graded each potential source of bias as high, low or unclear and
provided evidence from the study report together with a justifica-
tion for our judgement in the ’Risk of bias’ table. We summarised
the ’Risk of bias’ judgements across different studies for each of
the domains listed. Where information on risk of bias relates to
unpublished data or correspondence with a trialist, we noted this
in the ’Risk of bias’ table.
When considering treatment effects, we took into account the risk
of bias for the studies that contributed to that outcome.
In addition to routine risk of bias, we also undertook to understand
bias in the creation of the SMS. To obtain more information about
how the text messages were written, we contacted all authors to
request the following information.
1. Is the SMS intervention a reminder?
2. Did the authors describe the process to construct the
content of the text messages?
3. Did they evaluate causes for non-adherence in the target
population?
4. Were psychological theories used to develop the messages to
target the identified behavioural determinants of non-adherence?
5. Were behaviour-change techniques employed to develop
the messages?
6. Were different text messages developed according to
participants’ characteristics?
Assessment of bias in conducting the systematic
review
We conducted the review according to this published protocol
and reported any deviations from it in the Differences between
protocol and review section of the systematic review.
Measures of treatment effect
We planned to analyse dichotomous data as odds ratios or risk
ratios with 95% confidence intervals and continuous data as mean
difference or standardised mean difference with 95% confidence
intervals. If it had been applicable, we would have entered data
presented as a scale with a consistent direction of effect.
We would have narratively described skewed data reported as me-
dians and interquartile ranges.
Unit of analysis issues
Wedid not include any cluster-randomised trials.We did not carry
out meta-analysis because of the heterogeneity of the included
studies with respect to their methods, population and outcome
measures. Therefore, we did not have any unit of analysis issues.
Dealing with missing data
We contacted investigators to verify key study characteristics and
obtain missing numerical outcome data where possible (e.g. when
a study was identified as abstract only).
Assessment of heterogeneity
The included trials were too heterogeneous in methods, popula-
tion and outcome measures to pool the data in a meta-analysis.
We therefore described the studies narratively.
Assessment of reporting biases
We did not assess reporting bias with a funnel plot as we included
only seven studies which were too heterogenous to pool in a meta-
analysis.
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Data synthesis
We did not undertake meta-analyses as the included studies were
too heterogeneous in their methods, population and outcome
measures. Should more studies become available in future updates
of this review which enable meta-analyses, we will use a random-
effects model as we would still expect some degree of heterogene-
ity.
’Summary of findings’ table
We created a ’Summary of findings’ table using the following out-
come: adherence to treatment. We used the five GRADE consid-
erations (study limitations, consistency of effect, imprecision, in-
directness, and publication bias) to assess the quality of a body of
evidence as it relates to the studies for the prespecified outcome.
We used methods and recommendations described in Section 8.5
and Chapter 12 of the Cochrane Handbook for Systematic Reviews
of Interventions (Higgins 2011), using GRADEpro software. We
justified all decisions to downgrade the quality of studies using
footnotes and we made comments to aid the reader’s understand-
ing of the review where necessary.
Subgroup analysis and investigation of heterogeneity
We had planed to carry out the following subgroup analyses for
the primary outcome.
1. The baseline arteriosclerotic cardiovascular’ (ASCV)
condition (i.e. coronary artery disease, cerebrovascular artery
disease, peripheral artery disease, and atherosclerotic aortic
disease).
2. Age (non-elderly versus elderly, i.e. 64 or more years old).
3. According to the health system in the population
background (universal health systems versus others).
4. Income region (by World Bank income group).
5. Type of setting (private versus public, and rural versus
urban).
6. Time of duration of the intervention (less than one year
versus one year or more).
7. Time since cardiovascular event (less than one year versus
one year to two years versus two years or more).
8. Frequency of text messages (daily versus other).
9. How text messages are developed (theory-based, validated,
etc.).
10. If trials are text message only or text message plus phone
calls.
11. By different measurements of adherence reported in the
articles (for example MARS questionnaire, self-reported, pill
recounts, etc.).
However, we were unable to undertake meta-analyses and there-
fore unable to conduct subgroup analyses. In future updates of
this review, when more trials are available, we will re-examine the
subgroup analysis.
Sensitivity analysis
We planned to conduct a sensitivity analysis for studies with a low
risk of bias. As we were unable to undertake meta-analyses, no
sensitivity analysis was done.
Reaching conclusions
We based our conclusions only on findings from the narrative
synthesis of included studies for this review. We avoided making
recommendations for practice, and our implications for research
suggested priorities for future research and outlines the remaining
uncertainties.
R E S U L T S
Description of studies
Results of the search
The search of the databases retrieved 3987 records. The search
of the clinical trial registers retrieved an additional 103 records.
After de-duplication, 2567 records remained for title and abstract
screening which led to the exclusion of 2425 records. Therefore
142 records were assessed as full text. This lead to the exclusion of
113 records. Eight studies (16 references) were identified as ongo-
ing and seven studies (13 references) were eligible for inclusion.
A search for the clinical trial registry numbers of the eight on-
going studies revealed that three studies are completed but study
results are not published yet (NCT01642355; NCT02354040;
NCT02783287). One completed study is still classed as ongo-
ing (Chow 2015) as contact with the author revealed that a sub-
analysis for medication adherence is planned. We also identified a
published study protocol for one of the remaining ongoing studies
(NCT01642355) and added this report.
The flow of studies through the process is shown in Figure 1.
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Figure 1. Study flow diagram.
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Included studies
Details of the methods, participants, intervention, comparison
group and outcome measures for each of the studies included in
the review are shown in the Characteristics of included studies
table.
We included seven studies (Dale 2015a; Fang 2016; Kamal 2015;
Khonsari 2015; Pandey 2014; Park 2014a; Quilici 2013), which
are heterogeneous in theirmethods, population and outcomemea-
sures. One study (Pandey 2014) was only available as abstracts,
and despite attempts to contact the authors we were unable to
obtain further information.
Participants
The sample size of included studies ranged from34 (Pandey 2014)
to 521 (Quilici 2013) with a total across all seven studies of 1310,
of which 1225 completed follow-up.
All studies included participants with coronary heart disease ex-
cept Kamal 2015, that reported on stroke. In detail, Dale 2015a
included 80% participants with myocardial infarction, 7% with
unstable angina and 13% with angina. Two studies included par-
ticipants with acute coronary syndrome (Khonsari 2015; Quilici
2013), and two studies included participants with myocardial in-
farction (Pandey 2014; Park 2014a). One study included partici-
pants with chronic stable angina (Fang 2016). Participants in one
study had undergone coronary stenting for acute coronary syn-
drome (Quilici 2013).
The mean age ranged from 53.6 years (Fang 2016) to 64 years
(Quilici 2013).
All studies had over 70% males, with the exception of (Pandey
2014) that had 59% males, and Kamal 2015 that had 67.5%
males.
Settings
Five studies recruited from hospitals (large metropolitan hospitals
(Dale 2015a; Fang 2016), tertiary teaching hospital (Kamal 2015;
Khonsari 2015), non-profit community hospital (Park 2014a).
One study (Pandey 2014)was set in a cardiac rehabilitation facility.
The setting of one study is unknown (Quilici 2013).
Five studies reported the country in which they took place (China
(Fang 2016), New Zealand (Dale 2015a), Malaysia (Khonsari
2015), Pakistan (Kamal 2015), USA (Park 2014a)). The countries
are not reported for two studies (Pandey 2014; Quilici 2013) but
the affiliations of the authors suggest that one took place in France
(Quilici 2013) and one in USA (Pandey 2014).
Development of SMS
Authors were emailed about how SMS were created. We were able
to obtain responses from four studies (Dale 2015a; Khonsari 2015;
Park 2014a; Kamal 2015) the responses are summarised in Table
1.
Two studies reported that the SMS was developed as a reminder
to take their medications (Khonsari 2015; Park 2014a), and as a
result no work was put into their development.
One study specified that the automated computer program from
which the messages were sent was developed particularly for this
study (Pandey 2014). Four other studies stated that an automated
system was used (Dale 2015a; Kamal 2015; Park 2014a; Khonsari
2015), which can also be assumed for the remaining study but
was not explicitly stated (Quilici 2013). In detail, Dale 2015a
specified that “we created and refined the Text4Heart intervention
through formative and pre-testing studies following the mHealth
Development an Evaluation Framework” and “a SMS library of
503 messages has been developed. It is written in English at an
appropriate reading level (RMS 800 Lexile: approximately age 13
years) tested using the Lexile Analyzer 2013 software program
(MetaMetrics, Durham, NC, USA).” Park 2014a specified that
“The primary intervention for this research study was based on
Self-Efficacy Theory by Bandura. Briefly, this theory postulates
that in one’s capability to successfully perform certain behaviours
influences level ofmotivation, affective states, and action (Bandura
1997).”
No study reported evaluating causes for non-adherence in the
study. Dale 2015a and Khonsari 2015 reported on the psycholog-
ical and behaviour-change techniques used in the development of
their text messages (Table 1).
Three studies tailored the text messages to the participants’ name
(Dale 2015a; Khonsari 2015; Park 2014a). One study stated that
the messages were personalised without providing further details
(Quilici 2013). One study (Pandey 2014) did not provide infor-
mation on whether or not the messages were tailored. No study
detailed that text messages were tailored to individual patient char-
acteristics. Two studies stated that bi-directional text messaging
was required (Dale 2015a; Park 2014a). Participants were required
to respond back to confirm receipt (Park 2014a) or send their step
count, questions and feedback (Dale 2015a). One study stated
that the formulation of the text messages were different every day
(Quilici 2013).
Four studies provide details on the template texts used for the text
messages (Dale 2015a; Pandey 2014; Park 2014a; Khonsari 2015).
Dale 2015a, Kamal 2015, and Khonsari 2015 reported piloting
the questionnaires before conducting the study; Fang 2016 did
not discuss the method or timing of the SMS at all in the paper.
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Interventions
Duration of the intervention ranged from 30 days (Park 2014a;
Quilici 2013) to 12 months (Pandey 2014).
Daily text messages were sent in most studies (Khonsari 2015;
Pandey 2014; Park 2014a; Quilici 2013). One study (Dale 2015a)
sent daily text messages from week zero to 12 weeks, which were
reduced in week 13 to week 24 to five messages a week. One study
(Fang 2016) did not report on message frequency. Kamal 2015
stated that they were sent on “preset days of the week”, and at
particular times before each medication intake.
The control group was usual care in five studies (Dale 2015a;
Kamal 2015; Khonsari 2015; Pandey 2014; Quilici 2013), text
messaging for health education in one study (Park 2014a), and
monthly phone calls in one study (Fang 2016). Usual care in Dale
2015a consisted of the standard outpatient cardiac rehabilitation
program, involving education classes and supervised exercise.
Outcomes
All included studies measured adherence to medication. Quilici
2013 looked at aspirin adherence using self-reported adherence.
Two studies (Pandey 2014; Khonsari 2015) measured the over-
all adherence to several prescribed medications. Pandey 2014 in-
cluded participants on a once-daily regimen of aspirin, a beta-
blocker, an angiotensin converting enzyme (ACE) inhibitor or an-
giotensin receptor blocker (ARB) and a statin using self-reported
logs. Most participants in Khonsari 2015 were on five or more
daily medications, adherence was measured using the Morisky
Meidication Adherence Scale. One study measured adherence to
antiplatelet and statinmedications separately using both electronic
pill bottles and self-reported adherence (Park 2014a). One study
only looked at adherence to statins (Fang 2016). One study did
not specify which medications the participants were taking and
adherence was measured, but specified that it used self-reported
medication adherence (Dale 2015a).
One study reported on fatal cardiovascular events (Khonsari
2015).
Two studies provided outcome data for our secondary outcome of
blood pressure (Dale 2015a; Kamal 2015) and one study reported
onLDL cholesterol (Dale 2015a). Two studies reported on adverse
events (Dale 2015a; Quilici 2013).
Four studies did not report on any of our secondary outcomes
(Khonsari 2015; Pandey 2014; Park 2014a; Quilici 2013).
Funding
The source of funding was reported on in three studies - govern-
ment body (Dale 2015a), no funding received (Khonsari 2015),
and research materials from not-for-profit organisation but for-
profit organisation provided use of the mobile Health manager
platform (Park 2014a).
Excluded studies
Details of excluded studieswhichmost closelymissed the inclusion
criteria can be found in the Characteristics of excluded studies
table.
Ongoing studies
We
have identified eight ongoing studies (ACTRN12616000422426;
Chow 2015; NCT01642355; NCT02336919; NCT02354040;
NCT02783287; NCT02883842; NCT02888769). Five are
from high-income countries (New Zealand, 330 participants,
ACTRN12616000422426; Australia, 710 participants Chow
2015; USA, 400 participants NCT01642355; Canada, 75 partic-
ipants NCT02336919, and 84 participants NCT02783287), one
from a lower middle-income country (Pakistan, 200 participants
NCT02354040), and two from an upper middle-income country
(China, NCT02883842; NCT02888769). Details can be found
in the Characteristics of ongoing studies table.
Risk of bias in included studies
Details are provided for each of the included studies in the ’Risk
of bias’ tables in Characteristics of included studies and in Figure
2 and Figure 3. Overall, studies were assessed as having high or
unclear bias across multiple domains, and the quality was deemed
to be very low (Summary of findings for the main comparison).
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Figure 2. ’Risk of bias’ graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. ’Risk of bias’ summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
Four studies reported adequately on the random sequence gen-
eration and were therefore judged to be of low risk of bias in
this domain (Dale 2015a; Fang 2016; Kamal 2015; Park 2014a).
Three studies did not provide enough information and are there-
fore judged to be unclear risk of bias (Khonsari 2015; Pandey
2014; Quilici 2013).
Three studies reported adequately on allocation concealment and
were judged to be of low risk of bias in this domain (Dale 2015a;
Kamal 2015; Park 2014a). Four studies did not provide enough
information and are therefore judged to be unclear risk of bias
(Fang 2016; Khonsari 2015; Pandey 2014; Quilici 2013).
Blinding
While blinding of the participants is not possible with this inter-
vention, blinding of outcome assessors could have been done. Two
studies (Dale 2015a; Khonsari 2015) clearly state that no blinding
occurred and are therefore at high risk of bias. Five studies (Fang
2016; Kamal 2015; Pandey 2014; Park 2014a; Quilici 2013) did
not report on this domain and are therefore judged to be of unclear
risk of bias.
Incomplete outcome data
Six studies had less than 8% loss to follow-up, comparable in
intervention and control group, and were judged to be at low risk
of incomplete outcome data. One study had 20% loss to follow-
up and was considered to be at high risk of bias (Kamal 2015).
Selective reporting
For two studies wewere able to access the trial protocol and all out-
comes planned were also reported on (Dale 2015a; Kamal 2015).
We therefore judged these studies to be of low risk of reporting
bias. One study (Quilici 2013) was judged to be of high risk of bias
in this domain as the data were minimal (published as a letter to
the editor), and details within the report differed. The other four
studies (Fang 2016; Khonsari 2015; Pandey 2014; Park 2014a)
are of unclear risk of bias as we did not identify a protocol or trial
registry entry to judge reporting bias.
Other potential sources of bias
Two studies were assessed as low risk of bias in this domain as they
were funded by a government body (Dale 2015a) and clearly stated
that no grant from any type of funding body has supported this
trial (Khonsari 2015). Five studies have been judged to be at high
(Pandey 2014; Park 2014a; Quilici 2013) or unclear (Fang 2016;
Kamal 2015) risk of bias. Pandey 2014 is an abstract publication
only and no contact with authors was possible to clarify missing
information, the funding source is unclear and differing details are
provided in two abstracts. Similarly with Quilici 2013, for which
the only source of information is a published letter to an editor
in which the outcome data for self-reported non-adherence differs
between the text and Figure 2. A for-profit organisation provided
use of the mobile Health manager platform in Park 2014a.
Effects of interventions
See: Summary of findings for the main comparison Mobile
phone text messaging to improve medication adherence in
secondary prevention of cardiovascular disease
Primary outcomes
Adherence to treatment
All seven included studies (1310 randomised participants) re-
ported on medication adherence. Due to the heterogeneity be-
tween the studies with respect to participants, methods and out-
come measures, we did not pool the results in a meta-analysis but
describe the results in narrative form.
Validated Survey measures
Five studies measured medication adherence with the Morisky
Medication Adherence Scale (MMAS-8) (Dale 2015a; Fang 2016;
Kamal 2015; Khonsari 2015; Park 2014a). MMAS-8 is a patient-
reported metric and validated tool that is widely used in adher-
ence research. Unfortunatetly the studies presented the results in
different ways, making it difficult to pool the studies. Dale 2015a,
with a follow-up of six months and 116 participants analysed re-
ports for the intervention group a “significantly greater medica-
tion adherence score (Mean Difference (MD) 0.58, 95% CI 0.19,
0.97; P=.004)”. In particular, this was aMMAS-8 score of 7.3 (SD
0.9) for the intervention group and 6.8 (SD 1.2) for the control
group at the six months follow-up. Fang 2016, had a three-arm
design with SMS, SMS + micro letter, or telephone calls (follow-
up of six months and 271 patients analysed) reported that partic-
ipants given SMS alone had reduced odds of being non-adherent
compared to telephone reminders (Odds Ratio (OR) 0.40 95%
CI 0.18 to 0.63) and patients that had SMS + micro letter had
the lowest odds compared to telephone reminders (OR 0.07, 95%
CI 0.03 to 0.15). Kamal 2015 (200 participants, two-month fol-
low-up) reported higher levels of adherence in the intervention
arm (adjusted MD 0.54, 95% CI 0.22 to 0.85). Khonsari 2015
(62 participants) reported that “the risk of being low adherent
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[(score 3-8 according toMorisky 1986)] among the control group
is 4.09 times greater than the intervention group (Relative Risk
(RR) 4.09, 95% CI 1.82 to 9.18)” at eight weeks follow-up. The
same study also reported end of follow-up at two months the low
adherence was 16.1% in the intervention group and 58.1% in the
control group. Park 2014a, with the shortest follow-up of 30 days
and 28 participants analysed in each group, reported a baseline
MMAS-8 score of 6.20 (SD 1.66) for the intervention group and
5.85 (SD 2.10) for the control group. At follow-up, the score had
risen for both groups, but was higher for the control group at 6.73
(SD 1.49) than for the intervention group at 6.43 (SD 1.22) (no
P value reported).
Objective Measures
In addition to the MMAS-8 score, Park 2014a used another mea-
sure to test for medication adherence. A Medication Event Moni-
toring System (opening of the two electronic pill bottles provided
a time-stamp corresponding with medication self-administration)
resulted in the following. Antiplatelet doses taken on schedule
were 86.2% (SD 15.4) in the intervention group and 85.7% (SD
18.2) in the control group. For statins, 84.1% (SD 19.4) of doses
were taken on schedule by the intervention group and 79.7% (SD
19.3) in the control group. The correct number of antiplatelet
doses taken were 88.0% (SD 14.0) in the intervention group and
87.2% (SD 16.5) in the control group. For statins, 85.4% (SD
16.6) correct number of doseswere taken in the intervention group
and 81.3% (SD 16.4) in the control group.
Self-Reported Measures
Pandey 2014 assessed medication adherence in 33 participants
with self-reported logs at 12 months. This resulted in 90% adher-
ence in the intervention group compared to 70% in the control
group (P < 0.0001).
At 30 days follow-up, data from Quilici 2013 self-reports differed
between the text and Figure 2, but showed a higher adherence in
the intervention group (96.4% (text)/97.2% (Figure 2)) than in
the control group (93.6% (text)/92.8 (Figure 2).The OR for self-
reported aspirin non-adherence as provided in the paper is 0.37,
95% CI 0.15 to 0.90, P = 0.02. The platelet testing confirmed
this by showing a 94.8% adherence in the intervention group and
88.8% in the control group. The paper reported the OR for non-
adherence as 0.43, 95% CI 0.22 to 0.86, P = 0.01.
Fatal cardiovascular events
One study reported two deaths due to acute coronary syndrome
(ACS) complications, both in the control group (Khonsari 2015).
Non-fatal cardiovascular events (coronary heart disease
(CHD), revascularisation, stroke)
No study reported this outcome.
Combined cardiovascular disease (CVD) event (fatal or non-
fatal events)
No study reported this outcome.
Secondary outcomes
Low-density lipoprotein (LDL)-cholesterol for the effect of
statins
One study (Dale 2015a) reported some evidence of a reduction of
LDL cholesterol (mmol/L) in the intervention arm (adjusted MD
at six months: -0.25, 95% CI -0.49 to 0.01, P = 0.053).
Blood pressure for antihypertensive drugs
Two studies reported on blood pressure. Dale 2015a reported no
difference between arms for change in blood pressure (mmHg)
(systolic blood pressure adjusted MD at six months 0.09, 95% CI
-6.43 to 6.61, P = 0.98; diastolic blood pressure -0.24, 95% CI
-3.86 to 3.38, P = 0.90). Kamal 2015 reported a slightly lower
mean diastolic blood pressure in intervention group (MD 2.6
mmHg 95% CI -5.5 to 0.15).
Heart rate for the effect of beta blockers
No study reported this outcome.
Urinary 11-dehydrothromboxane B2 for the antiplatelet
effects of aspirin
No study reported this outcome.
Adverse effects
No study reported repetitive thumb injury or road traffic crashes
or other adverse effects as related to the intervention.
D I S C U S S I O N
Summary of main results
In this review, we were only able to include seven trials with a
small number of participants. The seven included trials were small,
of variable length (one to 12 months), and heterogenous so we
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were unable to pool them for meta-analysis. Six out of the seven
trials showed a beneficial effect of interventions of mobile phone
text messaging for medication adherence (Dale 2015a; Fang 2016;
Kamal 2015; Khonsari 2015; Pandey 2014; Quilici 2013). One
trial (Park 2014a), using Morisky Medication Adherence Scale
(MMAS-8) showed an improved adherence score for the control
group compared to the intervention group.However, this was only
one outcome measure in the smallest of the included trials with
a short follow-up of 30 days. The other measures used to assess
adherence in Park 2014a also showed a beneficial effect of text
message reminders. Park 2014a also showed a beneficial effect of
reminders compared with education. Only one study reported on
fatal cardiovascular events (Khonsari 2015), and they reported two
deaths due to acute coronary syndrome (ACS) complications, both
of which were reported in the control group. No study reported
on any of the other primary outcomes.
Only one study (Dale 2015a) reported on the secondary outcomes
of low-density lipoprotein (LDL)-cholesterol, finding a small pos-
itive effect on lowering cholesterol. Two studies (Dale 2015a;
Kamal 2015) reported no strong evidence of an effect on lower-
ing blood pressure. Four authors replied to our questionnaire on
SMS development. No study reported examining causes of non-
adherence or provided SMS tailored to individual patient char-
acteristics. No study reported adverse effects that related to the
intervention.
Overall completeness and applicability of
evidence
The evidence of this review is applicable to a predominantly male
population aged between 50 to 65 years, with coronary heart
(CHD) disease recruited soon after the index event and with a
short follow-up, usually less than six months. The studies were
mainly on CHD, with only one study examining stroke so the
results are not applicable to other cardiovascular diseases.
Two trials for which information on the country is available
took place in high-income countries (New Zealand and USA)
and two took place in upper middle-income countries (China
and Malaysia), and only one was conducted in a lower mid-
dle-income country (Pakistan) (Worldbank 2015). It is uncertain
where the other two studies were conducted, but they were likely
from high-income countries (France and USA). It is therefore un-
clear whether the results would apply to low- and middle-income
countries. Access to mobile phone technology does not seem to
be a problem in low- and middle-income countries (Worldbank
2012). We identified eight ongoing studies, that ranged from 75
individuals (NCT02336919) to 710 individuals (Chow 2015).
Five of these studies are being conducted in high-income coun-
tries (ACTRN12616000422426; Chow 2015; NCT01642355;
NCT02336919; NCT02783287).
Most of the studies examined medications and diseases singly, this
has implications for the generalisability of results, given that most
people may have co-morbidities, or be on multiple medications.
Quality of the evidence
Overall the ’Summary of findings’ table shows that the evidence
is of very low quality. The studies were small, heterogenous and
underpowered for the following reasons: Dale 2015a provided
a sample size calculation in the trial protocol but the primary
outcome was not medication adherence; Quilici 2013 was a ’pilot
study’; Park 2014a was reported as ’a convenience sample’. The
studies were generally of short duration, with two trials only lasting
30 days.
Each study has at least one risk of bias domain judged as high risk.
All studies were either at high or unclear risk of bias for blinding;
both performance and detection bias, and only three studies (Dale
2015a; Kamal 2015; Park 2014a) were at low risk for allocation
concealment and random sequence generation. Although all stud-
ies used mobile phones as the way to deliver the intervention, we
identified substantial differences in the actual content of the SMS.
Only one study (Dale 2015a) used behaviour-change models to
develop the content of the intervention, while two other studies
used just “reminders”, and for the other two there was lack of in-
formation for review authors to judge what type of content was
used in the SMS. This heterogeneity not only has implications to
the applicability of the evidence, but also raised the questions that
quality of reporting for trials evaluating mobile phone interven-
tions is very poor.
Potential biases in the review process
We acknowledge that, although systematic searches across a num-
ber of resources were conducted, any search has limitations for
pragmatic reasons. Publication bias is a known problem for trials
with negative results (Hopewell 2009). We tried to overcome this
potential limitation by searching clinical trial registries for data on
prospectively registered trials.
One of the studies was only reported in abstract form (Pandey
2014), and while we attempted to contact the authors on multiple
occasions we were unable to obtain further information on this
study.
Due to the heterogeneity of the identified trials we did not per-
form ameta-analysis and therefore this review cannot benefit from
pooled estimates based on a larger sample size than the individual
trials.
Agreements and disagreements with other
studies or reviews
While there is not a great deal of evidence on mobile text mes-
saging for adherence in secondary prevention, It can be useful
to look into research into what has been successful in tackling
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other chronic conditions (for example Viswanathan 2012). Our
results are broadly in line with studies in other disciplines that have
showed some promising results; particularly in the field of HIV
research Anglada-Martinez 2015, a systematic review of 20 gener-
ally low-quality studies (7402 participants) of mhealth for adher-
ence to HIV mediations found a great deal of heterogeneity, but
reported 65% of studies reported a positive effect of mhealth on
adherence. Another systematic review (Devi 2015) that included
mHealth on adherence to medications found 70% (33 of 47) of
studies reported positive effects. Al-Ganmi and colleagues con-
ducted a systematic review looking at cardiovascular medication
adherence in cardiac patients, and also found too much hetero-
geneity of results to conduct meta-analysis (Al-Ganmi 2016). In a
large systematic review of mhealth for behaviour-change and dis-
ease management, Free 2013 found that text message-based inter-
ventions increased adherence to antiretroviral (ART) and smoking
cessation.One study onmobile textmessaging for adherence on all
chronic diseases found that mobile text messaging nearly doubled
the odds of medication adherence (Thakkar 2016). Our study is
the first review to include an assessment of SMS development.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
While the studies suggested positive effects of mobile text mes-
saging for adherence to medications, the findings are of very low
quality, and we were unable to conduct meta-analysis. As a result
we have very little confidence in the findings, and cannot make
recommendations for practice.
Implications for research
Mobile text messaging appears to have positive effects on adher-
ence to medications for secondary prevention of cardiovascular
disease (CVD), with very little evidence of adverse events. How-
ever, there is a lack of high quality evidence. Although wewere able
to identify eight ongoing studies, most of these are from high-in-
come countries. As a result we call for more, adequately powered,
good quality, randomised studies to be conducted, particularly in
low-resource settings. Because in most cases there is a need for life-
long adherence to medications longer-term trials are also needed.
Future studies should also examine the frequency and timings that
the messages should be sent; message content; optimal develop-
ment processes, and process evaluations to assess the mechanisms
by which messages have effect. It is of particular importance that
standardised approaches to measure adherence (development of
free and validated scores) are used so that outcomes can be pooled
across studies.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Dale 2015a
Methods Design: two-arm, parallel RCT
Setting: two large metropolitan hospitals, Auckland, New Zealand
Recruitment period: over 10 months between 2013 and 2014
Length of intervention: 6 months
Two-arm, parallel, RCT
Participants Inclusion criteria: “Included participants were English-speaking adults with a docu-
mented diagnosis of CHD (myocardial infarction, angina, or revascularization). [...] ac-
cess to the Internet was a requirement. [...] phones were supplied for the duration of the
study if necessary.”
Exclusion criteria: “Those with untreated ventricular tachycardia, severe heart failure,
life-threatening coexisting disease with life expectancy less than 1 year, and/or significant
exercise limitations for reasons other than CHD were excluded.”
Randomised: n = 123, n = 61 intervention, n = 62 control group
Number available for follow-up: n = 57 intervention (n = 2 withdrew due to medical
reasons, n = 2 withdrew due to being too busy), n = 59 control (n = 3 could not be
contacted)
Mean age in years (SD): 59.9 (11.1), intervention group: 59.0 (10.5), control group:
59.9 (11.8)
Sex (% male): 81.3, intervention group: 79, control group: 84
Interventions “All participants received usual care, which included inpatient rehabilitation and encour-
agement to attend center-based CR. Traditional CR offered at the hospital recruiting
sites in this study consisted of one 1-hour outpatient education program per week for 6
weeks at a hospital or community center covering a range of topics, including cardiovas-
cular risk factors, lifestyle change, and psychosocial support. Patients also were encour-
aged to attend a 16-session supervised exercise program at the participating hospital or
outpatient center. Participants could take part in usual care CR from point of discharge
to 6 months after their heart event.”
“All participants were telephoned at 3-months postrandomization to collect primary
outcome data. [...] At 6-months postrandomization, participants were seen at a clinic or
in a home setting for final follow-up assessment.”
Intervention group: “In addition to usual care, the intervention group received a 24-
weekmHealth program sent by automated daily text messages and access to a supporting
website commencingwithin aweek of the baseline assessment. [...]Messages were tailored
to participants’ name and preferred time of day to receive messages. From weeks 13 to
24, the frequency of messages decreased to 5 per week. Bidirectional messaging was used
because participants were prompted to text in their weekly pedometer step counts and
to ask questions or for feedback on other behaviors.”
Text type: automated, bidirectional
Control group: usual care as describe above
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Dale 2015a (Continued)
Outcomes Primary outcome: adherence to recommended health guidelines measured as a binary
variable using a self-reported composite health behavior score based on the European
Prospective Investigation into Cancer (EPIC)-Norfolk Prospective Population Study at
6 months (smoking status, physical activity, alcohol consumption, fruit and vegetable
intake)
Secondary outcomes: biomedical risk factors (systolic and diastolic blood pressure, lipid
profile, weight, BMI, waist-hip-ratio) and subsequent CHD risk probability, medication
adherencewasmeasuredusing theMorisky 8-itemMedicationAdherenceQuestionnaire,
serious adverse events, hospital anxiety, hospital depression, overall self-efficacy, overall
illness threat, engagement in the intervention
Medication adherence: at 6 months: intervention group 7.3 (0.9), control group 6.8
(1.2), adjusted mean difference 0.58, 95% CI 0.19 to 0.97
Blood pressure (mmHg) mean (SD): systolic: intervention group: 131 (17) at baseline,
136 (20) at 6months, control group: 129 (26) at baseline, 135 (16) at 6months, adjusted
mean difference at 6 months 0.09 (-6.43 to 6.61); diastolic: intervention group: 78 (11)
at baseline, 79 (11) at 6 months, control group: 75 (11) at baseline, 79 (10) at 6 months,
adjusted mean difference at 6 months -0.24 (-3.86 to 3.38)
LDL cholesterol (mmol/L) mean (SD): intervention group: 2.7 (1.3) at baseline, 1.7
(0.6) at 6 months, control group: 2.4 (1.0) at baseline, 1.9 (0.8) at 6 months, adjusted
mean difference at 6 months: -0.25 (-0.49 to 0.01)
Serious adverse events: n = 8 intervention group, n = 5 control group (“although none
were study related”)
Notes Funding: Government body (National Institute for Health Innovation, the University
of Auckland)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “randomization sequence was computer
generated by a statistician independent to
the project using a block size of 6”
Allocation concealment (selection bias) Low risk “allocation was concealed in sequentially
numbered, opaque, sealed envelopes. Par-
ticipant enrolment and assignment to the
intervention were completed by a trained
research assistant”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk “Because of the nature of the intervention,
participants and outcome assessors were
not blinded to their treatment allocation.”
Blinding of outcome assessment (detection
bias)
All outcomes
High risk “Because of the nature of the intervention,
participants and outcome assessors were
not blinded to their treatment allocation.”
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Dale 2015a (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Similar loss to follow-up in both groups
Selective reporting (reporting bias) Low risk Outcomes reported as planned in protocol
Other bias Low risk Funding from government body
Fang 2016
Methods Design: three-arm, parallel RCT (arm 1: SMS, arm 2: SMS +Micro letter, arm 3: phone)
Setting: Chengdu City, China
Recruitment period: over 10 months in 2013
Length of intervention: 6 months
Participants Inclusion criteria: adult patientswithCADtreated in theGeneralMedicineDepartment
at West China Hospital. All patients had chronic stable angina consistent with criteria
of the Chinese Medical Association of Cardiovascular Disease Guide
Exclusion criteria: (1) nonconformance with the diagnostic standards for chronic stable
angina established by the Chinese Medical Association of Cardiovascular Epidemiology,
(2) history of mental illness, (3) infection, fever, operation, serious heart failure, respi-
ratory failure or acute stroke in the prior month and (4) inability to use a mobile phone
that accepts SMS
Randomised: n = 280, arm 1: 95, arm 2: 92, arm 3: 93
Number available for follow-up: n = 271. Nine withdrew for either unwillingness to
complete (6) personal issues (3) arm 1 n = 4, arm 2 n = 2, arm 3 n = 3
Mean age in years (SD): arm 1 = 53.73 (7.20), arm 2 = 53.69 (7.74), arm 3 = 53.50
(7.62)
Sex (% male): arm 1 = 70.33 arm 2 = 67.78, arm 3 = 67.78
Disease duration (average years): arm 1 = 3.02 years, arm 2 = 2.98, arm 3 = 2.94
Interventions All patients received initial questionnaires at the hospital. The SMS group received
medication reminders and educational materials via SMS. The SMS + Micro Letter
group received medication reminders via SMS and educational materials via ML. We
built a public ML platform, from which we regularly released CAD-related information,
including the hazards and methods of preventing hyperlipidaemia, the role, scope, usage,
method of use, and side effects of lipid-lowering drugs and other related information.
Patients in the SMS +ML group had open access to all information on theML platform.
The phone group received a telephone call once a month to remind them of their
medication schedule and upcoming appointments. After six months, we compared statin
prescription adherence among the three groups
Text type: Not stated
Outcomes Primary outcome: adherence to statin medication using the Morisky Medication Ad-
herence Scale (MMAS)
Medication adherence: at baseline: Arm 1 2.88 (0.71), Arm 2 2.86 (0.71), Arm 3 2.86
(0.87),
at six months:
Arm 1 (SMS only compared to phone) OR 0.40 (0.18, 0.63)
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Fang 2016 (Continued)
Arm 2 (SMS + ML compared to phone) OR 0.07 (0.03, 0.15)
Serious adverse events: Not discussed
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Patients were randomised using a com-
puter-generated random number table
Allocation concealment (selection bias) Unclear risk Not discussed
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not discussed but given nature of interven-
tion unlikely
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not discussed
Incomplete outcome data (attrition bias)
All outcomes
Low risk Similar loss to follow-up in both groups
Selective reporting (reporting bias) Unclear risk Only one outcome, but no protocol
Other bias Unclear risk None discussed
Kamal 2015
Methods Design: two-arm, parallel RCT
Setting: Karachi, Pakistan
Recruitment period: not stated
Length of intervention: 2 months
Participants Inclusion criteria: age greater than 18 years old; history of stroke(s) confirmed by
neuroimaging at the time of the episode; more than 1 month since last episode of
stroke; use of at least two drugs such as (but not limited to) antiplatelets, statins, anti-
hypertensives to control risk factors of stroke; modified Rankin Score of 3 or less (so
that they are able to operate mobile phones); possession of a personal cell phone that the
patient has access to at all times. In the case of patients who do not own or are unable to
use mobile phones, they must have a caregiver available at all times who possesses a cell
phone; ability to receive, comprehend and reply to an SMS in English, Nastaleeq Urdu
(local Urdu script) or Roman Urdu. In the case of patients who themselves are unable to
receive, comprehend or reply to an SMS, they must have caregivers available at all times
who could perform the above mentioned tasks
Exclusion criteria: biological impairment in reading or responding to SMS in the care-
giver such as (but not limited to) loss of vision, visual field cuts, aphasia in case the patient
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himself/herself is supposed to receive SMS; Diagnosed organ dysfunction or malignancy
such as hepatic, renal or malignancy; plans to travel outside the country inside the two
months following enrolment
Randomised: n = 200. Intervention = 100, control = 100
Number available for follow-up: n = 162. Intervention arm: 17 lost to follow-up: 10
unwilling to come, 2 sick, 3 out of station 2 discontinued intervention. Control arm:
21 lost to follow-up: 17 unwilling to come, 4 out of station
Mean age in years (SD): Control: 57.6 (1.3), intervention: 56 (1.5)
Sex (% male): 67.5 % male (64% in control 71% in intervention)
Disease duration: at least one month
Interventions Intervention: In addition to the usual care, intervention group received automated SMS
reminders customised to their individual prescription. The participants were required to
respond to the SMS stating if they have taken their medicines. Moreover, twice weekly
health information SMS were also sent to the intervention group. Health information
SMS were customised according to medical and drug profile of every patient by the
research team
Control: patients received the usual standard of care provided at the centre for stroke
patients. This primarily consisted of regular follow-up visits (as advised by their neurol-
ogist) with their stroke neurologist. In general, these were at 1, 3, 5,9,12 months after a
stroke. Each patient was provided with a telephone number that could be used to reach
the stroke team in case of an emergency and each patient was also reminded of their
clinic appointments 1-2 days prior via SMS and/or phone
Text type: automated- two-way
“The messages were designed in a weekly schedule at preset days of the week for total
8 weeks e.g., Wednesday and Saturday week 1 for patient X. The timings were decided
according to the prescription so that health messages do not collide with the reminder
messages for that day. Usually 5 pm was found feasible for most participants. These
messages did not ask for a reply. These health information SMSwere codified byMichie’s
Taxonomy of Behavioural Change for repeatability”
Outcomes Primary outcome: Change in medication adherence after 2 months using the Morisky
Medication Adherence Scale (MMAS)
Secondary Outcome: Change in blood pressure, acceptability of SMS
Medication adherence:
at baseline:
Control 6.6 (0.17) Intervention 6.6 (0.16)
at two months:
Control 6.7 (1.32) Intervention 7.4 (0.93)
Adjusted mean difference (adjusted for baseline, number of pills, dosing frequency, age,
gender, employment status, education, use of alarms)
0.54 (95% CI 0.22, 0.85)
Blood pressure
The mean diastolic blood pressure in the intervention group was 2.6 mmHg (95 % CI;
−5.5 to 0.15) lower compared to the usual care group
Serious adverse events: Not discussed
Notes
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Kamal 2015 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Central randomised computer-generated
sequence. The staff who randomised and
those who assessed and those who delivered
the intervention were separate
Allocation concealment (selection bias) Low risk Concealed in white envelopes
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not discussed but based on intervention
high risk
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Only mention is that “The staff who ran-
domized and those who assessed and those
who delivered the intervention were sepa-
rate”
Incomplete outcome data (attrition bias)
All outcomes
High risk 20% lost to follow-up
Selective reporting (reporting bias) Low risk All primary outcomes reported on. Blood
pressure notmentioned in protocol, but ac-
ceptability and patient satisfaction were
Other bias Unclear risk Nothing discussed
Khonsari 2015
Methods Design: prospective, parallel, two-arm
Setting: tertiary teaching hospital In Kuala Lumpar, Malaysia
Recruitment period: 23 January 2013 to 23 February 2013
Length of intervention: 8 weeks
Participants Inclusion criteria: ACS
Exclusion criteria: no cell phone to receive text messages; were not discharged during
the specified study timeline or were discharged to a care facility or transferred to another
health care institution; were illiterate or unable to read text messages; were not available
for the two-month period of the study (including being unavailable by phone and/or
travelling out of the country); or had been diagnosed with cognitive impairment so that
the informed consent process might be incomprehensible
Randomised: n = 62, n = 31 intervention group, n = 31 control group
Number available for follow-up: n = 31 intervention group, n = 29 control (n = 2
death)
Mean age in years: intervention (56), control (59)
Sex (% male): intervention (87.1), control (83.9)
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Interventions Intervention group: The participants randomised to the intervention group received
text-message reminders based on the following template before every medication intake,
starting the day after discharge: “[Mr/Ms] [Patient’s Name], please take [Medication
Quantity] tablet of [Medication Name] at [Time]”. When the course of medication
was completed (patients were given a 30-day dosage), a message was sent to remind the
patients to come to the hospital and have their prescribed cardiac medications refilled.
The SMS reminder service was continued until twomonths after discharge. The system is
aweb-based softwarewhere all tasks are handled automatically. Reminderswere generated
and sent to each participant in the intervention group before every cardiac medication
intake in an 8-week programme. The researcher also followed up with the participants
in the SMS group via telephone calls once per two weeks during the study to reassure the
delivery of text messages, to enquire whether any emergency readmission was needed as
well as to show up for their appointments
Text type: Automated, one-way
Control group: Usual care for ACS post-discharge including cardiac rehabilitation and
follow-up appointments with the cardiologist, usually occurring at six or eight weeks
following discharge
Outcomes Primary outcome: medication adherence, measured with eight-item Morisky Medica-
tion Adherence Scale (MMAS-8-item)
Secondary outcomes: NYHA classification, death, hospital readmission rates, patient’s
perception on the automated short message service
Medication adherence: intervention (64.5% (n = 20) high adherence; 16.1% (n = 5)
low adherence); control (12.9% (n = 4) high adherence; 58.1% (n = 18) low adherence)
; risk of being low adherent among the control group is 4.09 times greater than the
intervention group (RR = 4.09, 95%CI 1.82 to 9.18)
Death: intervention (n = 0); control (n = 2) due to ACS complication
Notes Funding: “This research received no specific grant from any funding agency in the
public, commercial, or not-for-profit sectors.”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details reported
Allocation concealment (selection bias) Unclear risk No details reported
Blinding of participants and personnel
(performance bias)
All outcomes
High risk “Due to the nature of the intervention, it
was impossible to blind either the subjects
or the researchers to the study group assign-
ment.”
Blinding of outcome assessment (detection
bias)
All outcomes
High risk “To prevent potential bias in the results
of the study, all participants were visited
by cardiologists and cardiac rehabilitation
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specialists who were unaware of the study
group assignment to assess the participants’
heart function status based on the New
York Heart Association Functional Classi-
fication (NYHA) at the endpoint of the
study”
However, NYHA class was not an outcome
of this review and no blinding of outcome
assessors was done in relation to the other
outcomes
Incomplete outcome data (attrition bias)
All outcomes
Low risk “intention-to-treat analysis was performed
assuming that patients who were missing
were categorised under the low medication
adherence level as well as the last classifi-
cation of heart functional status in the pa-
tient’s most recent document.”
Selective reporting (reporting bias) Unclear risk No trial registry entry or published pro-
tocol found to compare planned with re-
ported outcomes
Other bias Low risk No specific funding
Pandey 2014
Methods Design: prospective, parallel, two-arm
Setting: cardiac rehabilitation facility, country not reported
Recruitment period: not reported
Length of intervention: 12 months
Participants Inclusion criteria: recently discharged afterMIwhowere receiving care at a single cardiac
rehabilitation facility; had to be on a once daily regimen of aspirin, a beta-blocker, an
ACE or ARB and a statin
Exclusion criteria: patients without cell phones and those unable to provide informed
consent in English were excluded
Randomised: n = 34, not separately reported for intervention and control group
Number available for follow-up: n = 1 dropout of control group, no reason
Mean age in years: total (63 in Pandey 2014, 64 in Pandey 2015), not separately reported
for intervention and control group
Sex (% male): total (59% in Pandey 2014 2014, 64% in Pandey 2015), not separately
reported for intervention and control group
Interventions Intervention group: daily text message reminders at the times they were to take their
prescribedmedication; “Please take your morning medication now” and indicated which
medication they should take at that time
Text Type: automated
Control group: usual care
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Outcomes Primary outcome: medication adherence 12 months after randomisation assessed with
self-reported logs
Medication adherence: intervention (month 1 = 98%, month 12 = 90%); control
(month 1 = 92%, month 12 = 70%)
Notes Funding: not reported
Publication: Published abstracts only (two different abstracts published with some dif-
fering information. Authors contacted on multiple occasions to clarify data, but have
not responded)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details reported
Allocation concealment (selection bias) Unclear risk No details reported
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No details reported but we made the as-
sumption that given the nature of the in-
tervention it was impossible to blind
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No details reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk “One patient in the control group dropped
out and therefore did not have follow-up
data.”
Selective reporting (reporting bias) Unclear risk No trial registry entry or published pro-
tocol found to compare planned with re-
ported outcomes
Other bias High risk Abstract publication only, no contact with
authors possible, funding source unclear,
differing details in two abstracts
Park 2014a
Methods Design: prospective, parallel, three-arm
Setting: non-profit community hospital, Northern California, USA
Recruitment period: April 2012 to March 2013
Length of intervention: 30 days
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Participants Inclusion criteria:≥21 years of age, hospitalised for non-ST elevationMI, ST elevation
MI or PCI, prescribed an antiplatelet medication [thienopyridine class of ADP receptor
inhibitors and/or a cycloozygenase inhibitor (i.e. aspirin), prescribed a statin medication
(HMG-CoA reductase inhibitors), owned amobile phone with text messaging capability
and were able to speak, read, and understand English
Exclusion criteria: cognitive impairment that limited ability to understand and complete
questionnaires, and inability to operate a mobile phone
Randomised: n = 90 total, n = 30 intervention group 1, n = 30 intervention group 2, n
= 30 control group
Number available for follow-up: n = 84, n = 28 intervention group 1 (n = 2 lost to
follow-up, withdrew due to illness), n = 28 intervention group 2 (n = 2 lost to follow-
up, of which n = 1 withdrew due to busy schedule and n = 1 withdrew due to illness), n
= 28 control group (n = 2 lost to follow = up, of which n = 1 due to privacy request and
n = 1 was unable to contact)
Mean age in years (SD): 59.2 total, 58.2 (10.6) intervention group 1, 58.3 (8.5) inter-
vention group 2, 61.1 (9.1) control group
Sex (% male): 76 total, 76.7 intervention group 1, 66.7 intervention group 2, 83.3
control group
Interventions Intervention group 1: text messages for medication reminders and health education;
The medication reminders were two-way, requiring patients to respond back to confirm
receipt. They were delivered, twice daily, at times selected by the patients that correlated
with their medication schedule). An example of a medication reminder was, “John, take
Plavix 75 mg at 9:00 AM. Respond with 1.”
Intervention group 2: text messages for health education; health education messages
were one-way educational health messages on cardiovascular risk reduction on Monday,
Wednesday, and Friday at 2 PM
Text type: sent from a customisable program through CareSpeak Communications “mo-
bile Health manager” platform (New Jersey), two-way
Control group: no text messages
For the purpose of the review, the two intervention arms were compared - intervention
group 1 (intervention), intervention group 2 (control)
Outcomes Primary outcome: medication adherence, measured by Medication Event Monitoring
System (opening of he two electronic pill bottles provided a time-stamp corresponding
with medication self-administration), responses to messages and MMAS-8, a self-report
measure completed at baseline and follow-up
Secondary outcomes: feasibility andpatient satisfaction, assessed by successful execution
of the intervention, patient participation, and by the Mobile Phone use Questionnaire
(developed for this study)
Medication adherence:
MEMS, per cent (SD) doses taken on schedule in % (SD) (antiplatelets): Intervention
group (analysed n = 24): 86.2 (15.4), control group (analysed n = 19): 85.7 (18.2)
MEMS, per cent (SD) doses taken on schedule in % (SD) (statins): Intervention group
(analysed n = 24): 84.1 (19.4), control group (analysed n = 20): 79.7 (19.3)
responses to messages, mean response rate in % (SD) (antiplatelets): M = 90.2 (9)
responses to messages, mean response rate in % (SD) (statins): M = 83.4 (15.8)
MMAS-8 score (SD): intervention group (analysed n = 28): baseline 6.20 (1.66), follow-
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up 6.43 (1.22), control group (analysed n = 28): baseline 5.85 (2.10), follow-up 6.73
(1.49)
Notes Funding: research materials from not-for profit organisations, for-profit organisation
provided use of the mobile Health manager platform
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Group assignment was generated by ran-
dom allocation sequence using blocks of six
that was prepared by a biostatistician.”
Allocation concealment (selection bias) Low risk “sealed opaque envelopes”; “The PI as-
signed patients to their groups by distribut-
ing envelopes in consecutive, numbered or-
der.”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk “Due to the nature of the study design,
the PI and patients could not be blinded
to the intervention once group assignment
was determined.”
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No details reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk Loss-to follow-up equal in both groups in-
cluded in the analyses
Selective reporting (reporting bias) Unclear risk No trial registry entry or published pro-
tocol available (confirmed by author via
email)
Other bias High risk For-profit organisation provided use of the
mobile Health manager platform
Quilici 2013
Methods Design: prospective, parallel, two-arm
Setting: not reported
Recruitment period:
Length of intervention: 1 month/30 days
Participants Inclusion criteria: patients were considered eligible to enter the study if they undergone
coronary stenting for ACS with good in-hospital aspirin response defined by arachidonic
acid induced platelet aggregation (AA-Ag) lower than 30%. Participants needed to own
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a mobile phone with ability to communicate via short message service (SMS). Patients
were discharged with a prescription of aspirin 75 mg and clopidogrel and were provided
with educational sessions highlighting the importance of patient adherence to physi-
cians’ recommendations. Patients, randomised to SMS, received for one month a daily
personalised SMS reminding aspirin intake, with different formulation every day
Exclusion criteria: not reported
Randomised: n = 521 total, n = 262 intervention group, n = 259 control group
Number available for follow-up: n = 250 intervention group (n = 12 withdrew, no
reasons), n = 249 control group (n = 10 withdrew, no reasons)
Mean age in years (SD): 64 (14) intervention group, 64 (10) control group
Sex (% male): 78% intervention group, 75.1 control group
Interventions Intervention group: patients received daily personalised SMS reminding of aspirin
intake, with different formulation every day
Text Type: personalised computer-generated
Control group: standard care
Outcomes Primary outcome: aspirin adherence, measured by self-report (oral and paper question-
naire) and platelet function testing, good adherence was defined as more than 95% of
prescribed doses in the past 30 days
Medication adherence: self-report - adherence (%): 96.4 (in text), 97.2 (in fig 2) in
intervention group, 93.6 (in text), 92.8 (in table 2) in control group platelet testing -
adherence (%): 94.8 in intervention group, 88.8 in control group (OR for non-adher-
ence: 0.43, 95% CI 0.22 to 0.86)
Adverse events: 20/41 non-adherent participants stopped the medication “because of
side effects, mainly bleeding”
Notes Funding: not reported
Publication:Published letter to the editor, outcome data for self-reported non-adherence
differs between text and Figure 2
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details reported
Allocation concealment (selection bias) Unclear risk No details reported
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No details reported but we made the as-
sumption that given the nature of the in-
tervention it was impossible to blind
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No details reported
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Incomplete outcome data (attrition bias)
All outcomes
Low risk Loss to follow-up similar in both groups
Selective reporting (reporting bias) High risk Minimal data, no trial protocol found
Other bias High risk Ooutcome data for self-reported non-ad-
herence differ between text and Figure 2
ACE: angiotensin-converting enzyme
ACS: acute coronary syndrome
ADP: Adenosine diphosphate
ARBs: angiotensin receptor blockers
BMI: body mass index
CAD: coronary artery disease
CHD: coronary heart disease
CI: confidence interval
CR: cardiac rehabilitation
LDL: low-density lipoprotein
MI: myocardial infarction
PCI: percutaneous coronary intervention
RCT: randomised controlled trial
RR: risk ratio
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
ACTRN12611000388910 Wrong outcomes
ACTRN12611001196932 Wrong intervention
Anonymous 1998 Wrong study design
Anonymous 2008 Wrong intervention
Antypas 2014 Wrong outcome
Bekelman 2013 Wrong intervention
Bendelac 2014 Wrong intervention
Blasco 2012 Wrong outcome
Bobrow 2016 Wrong patient population (primary prevention)
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(Continued)
Boroumand 2016 Wrong outcome
Bove 2010 Wrong intervention
Brath 2013 Wrong patient population
Buis 2015 Wrong study design
Capomolla 2005 wrong intervention
Dale 2015c Wrong outcome
de Jongh 2012 Systematic review
Ferrante 2010 Wrong intervention
Frederix 2015 Wrong outcome
Fruhwald 2009 Wrong intervention
Gill 2013 Wrong intervention
Goldstein 2014 Intervention is an App, not an SMS
Golshahi 2015 Wrong patient population (primary prevention)
Hickey 2016 Wrong outcome
Karanam 2012 Wrong intervention
Karhula 2015 Wrong intervention
Kashem 2006 Wrong intervention
Kashem 2008 Wrong intervention
Kiselev 2011 Wrong study design
Kulshreshtha 2010 Wrong intervention
Lambert-Kerzner 2012 Wrong intervention
Lauffenburger 2016 Not a RCT
Liew 2009 Wrong outcome (non-attendance)
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(Continued)
Lounsbury 2015 Wrong study design
Maddison 2015 Wrong outcomes
Mortara 2006 Wrong intervention
NCT01752192 Wrong intervention
NCT02377960 Patient population hypertensive patients
Owolabi 2014 Wrong outcomes
Patel 2013 Wrong patient population
Patnaik 2014 Wrong patient population (primary prevention)
Petrella 2014 Wrong intervention
Piette 2015 Wrong patient population
Raiman 2013 Less than 50% of patients were for secondary prevention. Contacted authors, but unable to provide
data on subgroup
Sahu 2014a Systematic review
Saywell 2012 Wrong intervention
Scalvini 2004 Wrong intervention
Schiff 2010 Editorial
Seto 2011 Wrong intervention
Seto 2012 Wrong intervention
Snoek 2016 Wrong intervention
Tulder 2014 Wrong intervention
Varleta 2014 Wrong patient population
Varnfield 2012 Wrong intervention
Varnfield 2014 Wrong outcomes
Vodopivec-Jamsek 2012 Systematic review
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(Continued)
Walters 2012 Wrong outcomes
Wolf 2016 Wrong intervention
Yoo 2009 Wrong patient population
Yu 2015 Wrong intervention
Yudi 2016 Wrong intervention
RCT: randomised controlled trial
Characteristics of ongoing studies [ordered by study ID]
ACTRN12616000422426
Trial name or title Text4Heart Partnership
Methods Design: Prospective, parallel RCT
Setting: Auckland, New Zealand
Participants Expected: 330
Inclusion criteria: Aged 18-80, A documented diagnosis of an acute coronary syndrome (including myocar-
dial infarction [MI], unstable angina) or percutaneous coronary revascularisation procedure, are 18 years or
older, eligible for cardiac rehabilitation
Exclusion criteria: Untreated ventricular tachycardia, severe heart failure, life threatening co-existing disease
with life expectancy < 1 year, and significant exercise limitations other than cardiovascular disease
Interventions Intervention:Each participant in the intervention group will receive at minimum the basic heart health CR
program, consisting of 5 messages per week for 6 months. The general heart health messages provide overall
advice and support on undertaking lifestyle change, including, taking medication, being physically active,
eating healthy, and reducing alcohol consumption. One message per week on each topic is delivered for the
entire six months
Control group: Participants in the control arm will be offered the standard outpatient CR programme
provided by each hospital, which involves support and education provision to discharged patients, with
supervised exercise offered at all three participating hospitals for those wishing to participate (Phase 2 CR
usually of 6-12 weeks duration). During Phase 3, participants are encouraged to continue with their lifestyle
changes and join a cardiac club. Heart Guide Aotearoa is also offered at the discretion of cardiac nurses. Given
the proven effectiveness of CR, it would be unethical not to offer usual CR to all participants; therefore the
Intervention arm participants will be advised that they are able to access the usual CR programme in addition
to the mHealth intervention, if they wish to do so
Outcomes Primary outcome: Proportion of participants adhering tomedication at 24 weeks. Themedication adherence
measure in this trial will be prescription record-assessed adherence, defined as: a dispensed medication ratio of
80% for each of the classes of medications consistent with guideline recommended therapy (e.g., antiplatelet,
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ACTRN12616000422426 (Continued)
statin, and blood pressure lowering therapy, ACE-inhibitor and or a beta blocker)
Secondary outcomes: Adherence to recommended lifestyle behaviours, self-report medication adherence,
patient engagement, cost-effectiveness
Starting date 18/04/2016
Contact information Ralph Madison
National Institure for Health Innovation, The Unviersity of Auckland
Private Bag 92019, Wellesley Street, Auckland, 1001
Notes
Chow 2015
Trial name or title Tobacco, EXercise and dieT MEssages (TEXT ME): The effect of a semi-personalised lifestyle reminder text
message intervention on cardiovascular risk factors in patients with cardiovascular disease and those who are
at high risk of cardiovascular disease
Methods Design: prospective, parallel
Setting: large tertiary referral centre and university teaching hospital in Sydney, Australia
Follow-up: six months
Participants Inclusion criteria: older than 18 years, had documented CHD, and were able to provide informed consent.
CHD defined as documented prior MI, coronary artery bypass graft surgery, PCI or 50% or greater stenosis
in at least 1 major epicardial vessel on coronary angiography
Exclusion criteria: did not have an active mobile phone or sufficient English language proficiency to read
text messages
Randomized: 710 randomised, n = 352 intervention group, n = 358 control group
Number available for follow-up: n = 319 analysed in intervention group (n = 7 requested to stop, n = 4 died
during intervention period, n = 2 unable to contact at 6 months follow-up, n = 20 excluded due to missing
LDL-C measures at baseline, 6 months or both), n = 333 analysed in control group (n = 3 unable to contact
at 6 months, n = 1 died prior to 6 months follow-up, n = 21 excluded due to missing LDL-C measures at
baseline, 6 months or both)
Mean age in years (SD): 59 (41-75)
Sex (% male):
Interventions Both groups received 3 study management text messages providing them with their allocation assignment,
study contact details, and a reminder prior to the follow-up appointment
Intervention group: Participants received, in addition to usual care, the 6-month prevention program of
approximately 96 messages.Four text messages per week about medicines, general health information, diet,
physical activity and smoking cessation (where applicable). Text messages were semi-personalised (addressed
to participant’s preferred name). Each message was sent on 4 to 5 randomly selected weekdays and arrived
at random times of the day during working hours. The message management program selected messages for
each participant at random from a bank of messages. Participants were told not to respond to messages
Control group: Control participants received usual care, which generally included community follow-up
with the majority referred to inpatient cardiac rehabilitation, as determined by their usual physicians
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Chow 2015 (Continued)
Outcomes Primary outcome: low-density lipoprotein cholesterol (LDL-C) - fasting blood sample, level at 6 months,
analysed by local laboratories
Secondary outcomes: systolic blood pressure (measured using electronic device), body mass index (BMI),
physical activity (Global Physical Activity Questionnaire), smoking status, heart rate (measured using elec-
tronic device), waist circumference, proportions of patients taking
Starting date
Contact information A/Prof Clara Chow, cchow@georgeinstitute.org.au
Notes As it was not clear from paper, we emailed authors who confirmed that all participants received texts about
adherence tomedications. The authors also stated that medication adherence data are planned to be published
as a sub-analysis
Trial registry number: ACTRN12611000161921
NCT01642355
Trial name or title Investigation of Motivational interviewing and Prevention consults to Achieve Cardiovascular Targets (IM-
PACT)
Methods Design: Randomised controlled trial
Participants Estimated enrolment: 400
Inclusion Criteria:
• At least 21 years of age or older
• Particiants scheduled to undergo a percutaneous coronary or peripheral vascular intervention
• Patients must have the ability to understand and the willingness to sign a written informed consent
document
Exclusion Criteria:
• Life expectancy less than 1 year
• Inability to walk
Interventions Study conducted: USA
No Intervention: Usual Care: includes physician assistant and/or nurse-based medical and lifestyle recom-
mendations in consultation with cardiac catheterisation attending or patient’s clinical cardiologist to poten-
tially improve the patient’smedical and lifestyle regimen. Relevant educationalmaterial is routinely distributed
to patients
ActiveComparator: Prevention consult in addition to usual care, patients will receive a prevention consult by a
prevention fellow and attending following their intervention. The consult will include guideline-basedmedical
recommendations for optimisation of the patient’s medical regimen targeting dyslipidaemia, hypertension
and diabetes. In addition, each patient will be educated on the cardiovascular disease process and given
detailed lifestyle recommendations onphysical activity, improvednutrition, smoking cessation andmedication
adherence
Active Comparator: Consult & Behavioural Intervention In addition to usual care and prevention consult
(as detailed above), patients will receive a full motivational intervention program by a trained motivational
coach and text messages over 6 months
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NCT01642355 (Continued)
Outcomes Primary Outcome Measures: Reduction of Non-HDL cholesterol [ Time Frame: 6 months ]
Secondary Outcome Measures:
Lipids [ Time Frame: 6 months ] - LDL-C, HDL, triglycerides
Metabolic risk factors [ Time Frame: 6 months ] - weight, BMI, HbA1C, abdominal circumference
Physical Activity [ Time Frame: 6 months ] - Yale Physical Activity assessment (Part 2)
Nutrition [ Time Frame: 6 months ] - Northwest Lipid Research Clinic (NWLRC) Fat Intake Score and fruit
and vegetable assessment questions
Medication Adherence [ Time Frame: 6 months ] - Morisky-4 medication adherence survey
Optimal medical regimen [ Time Frame: 6 months ] - assessment of lipid-lowering and cardiovascular medi-
cation regimen
Quality of life [ Time Frame: 6 months ] - Euro Qual 5D survey
Smoking cessation [ Time Frame: 6 months ] - Patient-based Assessment and Counseling for Physical Activity
and Nutrition (PACE) smoking assessment
Cardiovascular risk [ Time Frame: 6 months ] - cardiovascular risk assessment score (i.e. Framingham)
Cardiovascular events [ Time Frame: 5 years ] - cardiovascular events and hospitalisations reported by phone
call follow-up to 5 years
Starting date June 2012
Contact information Ramsha Jabbar, Ramsha.Jabbar@nyumc.org
Eugenia Gianos, eugenia.gianos@nyumc.org
Notes This study has been completed but no results have been identified with the search
NCT02336919
Trial name or title The use of texting messaging to improve the hospital-community transition and prevent readmission in
patients with cardiovascular disease (Txt2Prevent)
Methods Randomised efficacy study with parallel assignment
Masking: Single-blind (Investigator)
Study location: Canada
Participants Estimated enrolment: 75
Inclusion criteria:
• Are acute coronary syndrome patients on the non-surgical ward who will be discharged home
• Own a phone with text-messaging capabilities and have the ability to access new text messages
• Have the ability to provide informed consent
• Hhave the ability to read and understand English
Interventions In addition to usual discharge treatment, the intervention arm will receive instructions and information for
acute coronary syndrome patients as well as the Txt2Prevent text-messaging program. The program will
include a variety of topics such as standard follow-up care reminders as well as general self-management and
healthy living texts. There will be two streams, one for current/recent smokers and one for non-smokers. Texts
will be sent out every 1-3 days for 60 days. All participants in the same stream will receive the same texts in
the same order
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NCT02336919 (Continued)
Outcomes Primary Outcome: Self-management
Secondary Outcomes: Medication adherence, health-related quality of life, hospital readmissions, mortality
Starting date September 2015
Contact information Contact: Scott Lear 604-682-2344 ext 62778 SLear@providencehealth.bc.ca
Contact: Emily Ross, 604-682-2344 ext 64874
SLear@providencehealth.bc.ca
Notes
NCT02354040
Trial name or title TalkingRx
Methods Randomised parallel arm study
Participants Estimated enrolment: 200
Inclusion criteria:
• Adult men and women ,18 years old
• Ischaemic stroke or CAD, which is stable and outpatient-based
• Own cell phone
Interventions Study conducted in Pakistan. Assigned to receive Health Literacy and Reminder Updates via the IT-based
intervention Talking Rx, in addition to Usual Care for patients in the intervention group. The physician-
written prescription for antiplatelets and statins will be transferred on an OMR sheet and will be scanned.
The information on the prescription (dose, name of the medication, duration, route or any other special
instruction) will be sent to the patients via a text and a voice SMS (in Urdu language). The patients also
receive an individualised code that helps them request for repeated reminders for their medication timings.
However, a weekly medication reminder SMS will be sent to the patients in the intervention arm
Outcomes Primary outcome: Medication adherence
Secondary outcome: Health literacy
Starting date March 2015
Contact information Dr. Ayeesha Kamran Kamal, Aga Khan University, Karachi, Pakistan
Notes The study has been completed but no study results were available at the time of search
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NCT02783287
Trial name or title The impact of textmessaging onmedication adherence and exercise regimen amongpost-myocardial infarction
patients
Methods Design: Parallel randomised control trial
Setting: Cambridge Cardiac Rehabilitation in Ontario, Canada
Participants 84 participants aged 18 years and older
Inclusion Criteria:
• Post-MI hospital discharge within 2 weeks
• Enrolled in cardiac rehabilitation
• Prescribed antiplatelets, beta-blockers, ACE-inhibitors or ARBs, and/or statins on 1x/day regimen (for
medication adherence trial)
• Prescribed exercise regimen (for exercise trial)
• Ability to read and write English
• Possession of a cell phone with text messaging capability
Exclusion Criteria:
• Age < 18
• Incarcerated individuals
• Unable to read and write English
• Not in possession of a cell phone
• Patients prescribed medication regimen > 1x/day
Interventions 2 trials: medication adherence and exercise adherence
Intervention
Text message reminder for medication adherence
Patients randomised to this arm receive one text message per day (at the scheduled time) reminding them to
take their medication
control:
Usual care for medication adherence.
Outcomes Primary Outcomes: Medication adherence (Time Frame: 12 months), Exercise frequency (Time Frame: 12
months)
Secondary Outcomes: Exercise duration (Time Frame: 12months), Full medication adherence (Time Frame:
12 months)
Starting date January 2012
Contact information Niteesh K Choudhry, MD, PhD Brigham and Women’s hospital
Notes This study has been completed but no results were available at the time of search. This study was sponsored
by Brigham and Women’s Hospital, Boston, Massachusetts
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NCT02883842
Trial name or title China PEACE 3: Cardiovascular Health And Texting-Diabetes Mellitus (CHAT-DM) Study
Methods Design: Parallel RCT
Setting: Fuwai Hospital Beijing, China
Participants Patients 19-90 years
Inclusion Criteria: Participants with coronary artery disease defined as history of myocardial infarction and
percutaneous coronary intervention (PCI), history of diabetes, capability to read and send text messages
Exclusion Criteria: assumed poor adherence, do not have an active mobile phone
Interventions Intervention:
Patients will receive regular semi-personalised text messages for 12 months. Each participants will receive 6
text messages per week, which will be sent at random times of the day (9.00 am, 12 noon, 4.00 pm). They will
receive one general messages, one hypertension message, one glucose control message, one lifestyle message,
one medication adherence message and one physical activity message per week
Control:
Participants in the control group will receive 2 thank-you messages per month and undertake routine clinical
practice
Outcomes Primary Outcomes: Change in glucose level measured by HbA1C level (Time Frame: 6 months; 12 months
)
Secondary Outcomes: Change in BMI according to national standards (Time Frame: 6 months; 12 months)
, Change in systolic blood pressure obtained in office during each interview (Time Frame: 6 months; 12
months), Change in level of physical activity measured via International Physical Activity Questionnaire
(IPAQ) scale (Time Frame: 6 months; 12 months ), Change in medication adherence measured via Morisky
scale (Time Frame: 6 months; 12 months)
Starting date August 2016
Contact information Xin Zheng, MD, PhD xin.zheng@fwoxford.org
Notes Sponsor: China National Center for Cardiovascular Diseases
NCT02888769
Trial name or title Cardiovascular Health And Texting (CHAT) Study
Methods Design: Parallel RCT
Participants Patients 19-90 years
Inclusion Criteria: Participants with CAD defined as history of MI and percutaneous coronary intervention
(PCI), capability to read and send text messages
Exclusion Criteria: History of diabetes, assumed poor adherence, do not have an active mobile phone
Interventions Intervention: Patients will receive regular semi-personalised text messages for 12 months. Each participants
will receive 6 text messages per week, which will be sent at random times of the day (9.00am, 12noon, 4.
00pm). Non-smokers will receive two general messages, two hypertension messages, one medication adher-
ence message and one physical activity message per week. Smokers will receive one general message, two
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NCT02888769 (Continued)
hypertension messages, one medication adherence message, one physical activity message and one smoking
cessation message per week
Control:Participants in the control group will receive 2 thank-youmessages permonth and undertake routine
clinical practice
Outcomes Primary Outcome: Change in systolic blood pressure obtained in office during each interview (Time Frame:
Baseline; 6months; 12 months)
Secondary Outcomes: Change in level of physical activity measured via International Physical Activity
Questionnaire (IPAQ) scale (Time Frame: Baseline; 6months; 12 months), Change in medication adherence
measured via Morisky scale (Time Frame: Baseline; 6months; 12 months), Change in proportion of non-
smokers (Time Frame: Baseline; 6months; 12 months)
Starting date August 2016
Contact information Xin Zheng, MD, PhD xin.zheng@fwoxford.org
Notes Sponsor: China National Center for Cardiovascular Diseases
ACE: angiotensin-converting enzyme
ARBs: angiotensin receptor blockers
BMI: body mass index
CAD: coronary artery disease
CHD: coronary heart disease
CR: cardiac rehabilitation
HDL-C: high-density lipoprotein
LDL-C: low-density lipoprotein cholesterol
MI: myocardial infarctionPCI: percutaneous coronary intervention
RCT: randomised controlled trial
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D A T A A N D A N A L Y S E S
This review has no analyses.
A D D I T I O N A L T A B L E S
Table 1. SMS development
Dale 2015a1 Khonsari
20151
Pandey 2014 Park 2014a1 Quilici 2013 Fang 2016 Kamal 2015
SMS =
reminder
No Yes no contact de-
tails available
Yes emailed 18/4/
2016
emailed
18/01/2017)
yes
Description of
process to de-
sign SMS
“We
created and re-
fined the
Text4Heart
interven-
tion through
formative
and pretesting
studies follow-
ing the
mHealth De-
velopment
and Eval-
uation Frame-
work.” (Dale
2014a)
Also an-
other study that
helped inform
the physical ac-
tiv-
ity component (
Dale 2015c).
The text-
messages
content was
based on the
World Health
Organization
(WHO) mul-
tidimensional
adherence
model (WHO
2003b). In
constructing
the content
of the text
messages, we
focused on the
most common
reasons for
medication
non-adherence
based on
the WHO
model that
are uninten-
tional on the
patient’s part
(forgetfulness
and carelessness
with medica-
tion usage),
and include a
therapy-related
dimension
(misunder-
standing of
treatment
No informa-
tion
- No
information
-
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Table 1. SMS development (Continued)
instructions:
meds name,
dosage and
timing)
(Gadkari
2012).
Evalu-
ation of causes
for non-
adherence
No Ac-
cording to the
study method,
patients
were recruited
during an ad-
mission for
ACS prior to
discharge from
the cardiology
ward. It means
that all patients
were primarily
diagnosed with
ACS with-
out any experi-
ence of taking
cardiac medi-
cations. There-
fore, evalu-
ating causes for
non-adher-
ence in the tar-
get population
was not appli-
cable.
No informa-
tion
- No
information
-
Used psycho-
logical theo-
ries to develop
SMS
Messages
were based on
social cognitive
theory and the
common sense
model (Dale
2014b)
The WHO
multidi-
mensional ad-
herence model (
WHO2003b)
that guided this
study included
many dif-
ferent aspects to
describe medi-
cation non-ad-
herence
behaviour in-
cluding psycho-
logical factors.
No Informa-
tion
- No
information
-
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Table 1. SMS development (Continued)
It is emphasised
that no single
determinant is
responsible
for non-adher-
ence to treat-
ment because
the adherence
phenomenon is
multidi-
mensional and
results from the
interplay of five
sets of factors
(dimensions)
including:
A. Social and
economic fac-
tors,
B. Therapy-re-
lated factors,
C. Condition-
related factors,
D. Healthcare
team and sys-
tem-related
factors and
E. Patient-re-
lated factors.
Used
behaviour-
change tech-
niques to de-
velop SMS
Yes - All mes-
sages
were coded ac-
cording to their
theoretical con-
struct and cor-
responding
BCT
Develop-
ment of the au-
tomated
SMS reminder
system in this
study was use-
ful for deploy-
ing spaced repe-
tition strategies
via textmessag-
ing. Basically,
spaced
repetition strat-
egy posits that
instruc-
tion which is
repeated at in-
tervals have a
great impact on
No informa-
tion
- No
information
-
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Table 1. SMS development (Continued)
improving
a behaviour (
Ebbinghaus
1885)
SMS designed
according
to participants
characteristics
No, but par-
ticipants could
pick messages
on the health
behaviour they
were
most interested
in changing
(Physical activ-
ity, healthy eat-
ing, smoking
cessation,
or stress man-
agement).Mes-
sages were also
personalised
with partici-
pant’s preferred
name.
No No informa-
tion
- No
information
-
Pilot phase to
evaluate clar-
ity, grammar
of SMS
Yes, we
pilot tested the
healthy eating
messages. Feed-
back from par-
ticipants was
used to refine
the messages (
Dale 2014a)
We piloted the
intervention
with a sample
size of ten car-
diac
patients during
the first stage of
the study. Dur-
ing this phase,
a variety of test
scenar-
ios and clar-
ity of SMS con-
tent were anal-
ysed and, con-
se-
quently, the re-
quired changes
and fixes were
applied in or-
der to
achieve the de-
sired functions.
No informa-
tion
- No
information
-
1Text in italics = communication from authors
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A P P E N D I C E S
Appendix 1. Search strategies
CENTRAL
#1MeSH descriptor: [Reminder Systems] this term only
#2MeSH descriptor: [Telemedicine] this term only
#3MeSH descriptor: [Cell Phones] explode all trees
#4sms
#5mms
#6short near/6 messag*
#7text near/6 messag*
#8texting
#9telemedicine*
#10reminder next/6 (text* or system* or messag*)
#11telehealth
#12mobile near/6 (health* or phone*)
#13mhealth
#14telemonitor*
#15#1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14
#16MeSH descriptor: [Cardiovascular Diseases] explode all trees
#17cardio*
#18cardia*
#19heart*
#20coronary*
#21angina*
#22ventric*
#23myocard*
#24pericard*
#25isch?em*
#26emboli*
#27arrhythmi*
#28thrombo*
#29atrial next fibrillat*
#30tachycardi*
#31endocardi*
#32(sick near/2 sinus)
#33MeSH descriptor: [Stroke] explode all trees
#34stroke or strokes
#35cerebrovasc*
#36cerebral next vascular
#37apoplexy
#38brain near/2 accident*
#39(brain* or cerebral or lacunar) near/2 infarct*
#40peripheral next arter* next disease*
#41aortic*
#42arterial near/2 occlus*
#43infarct*
#44#16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25 or #26 or #27 or #28 or #29 or #30 or #31 or #32 or #33 or
#34 or #35 or #36 or #37 or #38 or #39 or #40 or #41 or #42 or #43
#45#15 and #44
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MEDLINE OVID
1. Reminder Systems/
2. Telemedicine/
3. exp Cell Phones/
4. sms.tw.
5. mms.tw.
6. (short adj messag*).tw.
7. (text adj messag*).tw.
8. texting.tw.
9. telemedicine*.tw.
10. (reminder adj (text* or system* or messag*)).tw.
11. telehealth.tw.
12. (mobile adj (health* or phone*)).tw.
13. mhealth.tw.
14. telemonitor*.tw.
15. or/1-14
16. exp Cardiovascular Diseases/
17. cardio*.tw.
18. cardia*.tw.
19. heart*.tw.
20. coronary*.tw.
21. angina*.tw.
22. ventric*.tw.
23. myocard*.tw.
24. pericard*.tw.
25. isch?em*.tw.
26. emboli*.tw.
27. arrhythmi*.tw.
28. thrombo*.tw.
29. atrial fibrillat*.tw.
30. tachycardi*.tw.
31. endocardi*.tw.
32. (sick adj sinus).tw.
33. exp Stroke/
34. (stroke or strokes).tw.
35. cerebrovasc*.tw.
36. cerebral vascular.tw.
37. apoplexy.tw.
38. (brain adj2 accident*).tw.
39. ((brain* or cerebral or lacunar) adj2 infarct*).tw.
40. peripheral arter* disease*.tw.
41. aortic*.tw.
42. (arterial adj occlus*).tw.
43. infarct*.tw.
44. or/16-43
45. 15 and 44
46. randomized controlled trial.pt.
47. controlled clinical trial.pt.
48. randomized.ab.
49. placebo.ab.
50. drug therapy.fs.
51. randomly.ab.
53Mobile phone text messaging to improve medication adherence in secondary prevention of cardiovascular disease (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
52. trial.ab.
53. groups.ab.
54. 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53
55. exp animals/ not humans.sh.
56. 54 not 55
57. 45 and 56
Embase OVID
1. reminder system/
2. telemonitoring/
3. mobile phone/
4. sms.tw.
5. mms.tw.
6. (short adj messag*).tw.
7. (text adj messag*).tw.
8. texting.tw.
9. telemedicine*.tw.
10. (reminder adj (text* or system* or messag*)).tw.
11. telehealth.tw.
12. (mobile adj (health* or phone*)).tw.
13. mhealth.tw.
14. telemonitor*.tw.
15. or/1-14
16. exp cardiovascular disease/
17. cardio*.tw.
18. cardia*.tw.
19. heart*.tw.
20. coronary*.tw.
21. angina*.tw.
22. ventric*.tw.
23. myocard*.tw.
24. pericard*.tw.
25. isch?em*.tw.
26. emboli*.tw.
27. arrhythmi*.tw.
28. thrombo*.tw.
29. atrial fibrillat*.tw.
30. tachycardi*.tw.
31. endocardi*.tw.
32. (sick adj sinus).tw.
33. cerebrovascular accident/
34. (stroke or strokes).tw.
35. cerebrovasc*.tw.
36. cerebral vascular.tw.
37. apoplexy.tw.
38. (brain adj2 accident*).tw.
39. ((brain* or cerebral or lacunar) adj2 infarct*).tw.
40. peripheral arter* disease*.tw.
41. aortic*.tw.
42. (arterial adj occlus*).tw.
43. infarct*.tw.
44. or/16-43
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45. 15 and 44
46. random$.tw.
47. factorial$.tw.
48. crossover$.tw.
49. cross over$.tw.
50. cross-over$.tw.
51. placebo$.tw.
52. (doubl$ adj blind$).tw.
53. (singl$ adj blind$).tw.
54. assign$.tw.
55. allocat$.tw.
56. volunteer$.tw.
57. crossover procedure/
58. double blind procedure/
59. randomized controlled trial/
60. single blind procedure/
61. 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53 or 54 or 55 or 56 or 57 or 58 or 59 or 60
62. (animal/ or nonhuman/) not human/
63. 61 not 62
64. 45 and 63
Web of Science
#5 #4 AND #3
#4 TS=(random* or blind* or allocat* or assign* or trial* or placebo* or crossover* or cross-over*)
#3 #2 AND #1
#2 TS=( cardio* or cardia* or heart* or coronary* or angina* or ventric* or myocard* or pericard* or isch?em* or emboli* or arrhythmi*
or thrombo* or “atrial fibrillat*” or tachycardi* or endocardi* or “sick sinus” or stroke or strokes or cerebrovasc* or “cerebral vascular”
or apoplexy or “brain accident*” or infarct* or “peripheral arter* disease*” or aortic* or “arterial occlus*”)
#1 TS=(sms or mms or “short messag*” or “text messag*” or texting or telemedicine* or “reminder text*” or “reminder system*” or
“reminder messag*” or telehealth or “mobile health*” or “ mobile phone*” or mhealth or telemonitor*)
Clinicaltrials.gov
Advanced search:
study type: interventional studies
conditions: cardiovascular
interventions: text
WHO ICTRP
text AND cardio*
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in a meta-analysis but describe the results in narrative form.
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